Lecornu had been expected to give a speech on Tuesday outlining his policy programme, amid fraught discussions about the French budget.
Specialist lender Shawbrook has announced plans to float on the London Stock Exchange, in the latest listing news to offer a boost to the UK market.
SAO PAULO (Reuters) -Brazilian planemaker Embraer tied up a deal on Monday to sell four military cargo planes to Sweden to replace the European nation's aging aircraft, the latest under a joint ...
Tokyo stocks surged almost five percent to a record high Monday and the yen sank on bets that the new leader of Japan's ruling party will embark on a new era of loose monetary policy to kickstart the ...
The closures will affect fewer than 4% of the group’s 316 food shops. An M&S spokesman said: “As we look to modernise our food business and offer the best of M&S Food to more ...
Shares of Rolls-Royce Holdings plc RYCEY have surged 6.6% in the past month, outperforming both the Zacks Aerospace-Defense Equipment industry’s growth of 5.9% and the broader Zacks Aerospace sector’s ...
Jon Smith explains why the stock market performance over the past year could act as a big boost to the Aberdeen share price going forward. The post 1 key reason why the Aberdeen share price could ...
NVIDIA has reinforced its central role in artificial intelligence infrastructure with a multi-billion-dollar planned investment in OpenAI for next-generation AI data centers, complemented by expanded ...
Our writer looks at two of the worst-performing FTSE 100 stocks since October 2024. But could either of them be worthy of further consideration? The post Down 53% and 30% over the past year, is it ...
Costco Wholesale (COST) shares have seen mild movement lately, with a slight dip of just under 1% over the past month. Investors appear to be weighing recent performance as they look for the next ...
Asset managers whose companies oversee more than $1.5 trillion are urging the Bank of England to scrap bond sales they believe place unnecessary strain on Britain's government debt, while they also ...
Nimacimab monotherapy did not meet its primary endpoint for weight loss; preliminary pharmacokinetic analysis showed lower than expected drug exposure, potentially indicating the need for higher ...